Clinical trial
Open-label, Multicenter, Randomized, Controlled Trial of Hemodynamic Optimization Based on the Hypotension Prediction Index (HPI) Compared to Standard Practice in Adult Patients Undergoing Elective Major Abdominal Surgery.
NCT05569265 is registered in ClinicalTrials.gov with Maria José Clara Colomina Soler as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label, Multicenter, Randomized, Controlled Trial of Hemodynamic Optimization Based on the Hypotension Prediction Index (HPI) Compared to Standard Practice in Adult Patients Undergoing Elective Major Abdominal Surgery.
- Lead sponsor
- Maria José Clara Colomina Soler
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 8, 2022
- Completion date
- February 25, 2024
- Enrollment
- 958 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative acute kidney injury, postoperative complications